nordihydroguaiaretic acid

Nordihydroguaiaretic acid, usually shortened to NDGA, is a plant-derived antioxidant that has attracted decades of scientific interest for its unusually broad range of biological activities. Found mainly in the resin of the creosote bush that dominates the deserts of the American Southwest and northern Mexico, NDGA scavenges free radicals, blocks inflammatory enzymes, and has shown intriguing effects on aging, cancer, and infection in laboratory studies. Yet it also carries serious safety concerns, particularly liver toxicity, that have kept it from becoming a mainstream therapeutic agent despite all that promise.

The Creosote Bush and How NDGA Gets Made

NDGA belongs to a class of compounds called lignans, which plants build by linking together smaller molecules from their normal metabolic pathways. The creosote bush (Larrea tridentata) accumulates a complex mixture of these lignans in its waxy leaf resin, with NDGA being the most abundant.¹ NDGA can make up as much as half the resin content of the leaves, which is remarkably concentrated for a single bioactive compound.² A related species, Larrea divaricata, found further south in South America, produces NDGA as well.

The creosote bush is one of the most successful desert plants on the continent, and NDGA appears to be part of the reason why. The compound is phytotoxic: it dramatically reduces root growth of competing plants like barnyard grass, foxtail, ryegrass, lettuce, and alfalfa, though it does not prevent seed germination itself.³ This allelopathic effect, where one plant suppresses nearby competitors by releasing chemicals into the soil, helps explain the evenly spaced, almost geometric distribution patterns you see in mature creosote stands. The bush essentially poisons the ground around it to keep rivals from establishing.

How NDGA Works as an Antioxidant

The feature that first drew researchers to NDGA was its potent antioxidant behavior. The compound has four hydroxyl groups on its aromatic rings, which makes it exceptionally good at donating electrons to neutralize reactive oxygen species. Experimental work combining theory and lab tests found that the reaction between NDGA and hydroxyl radicals is so fast it approaches the physical speed limit for molecular interactions in solution. NDGA can scavenge at least two hydroxyl radicals per molecule, and it protects both proteins and DNA from damage caused by these radicals.⁴

Beyond scavenging free radicals directly, NDGA also blocks the enzyme pathways that generate inflammatory molecules in the first place. It inhibits both lipoxygenase and cyclooxygenase, which are the two major enzyme families responsible for producing leukotrienes and prostaglandins from arachidonic acid.⁵ This dual inhibition is somewhat unusual; most anti-inflammatory compounds target one pathway or the other, not both. The lipoxygenase-blocking activity in particular has made NDGA a widely used tool in laboratory research whenever scientists need to shut down that pathway to study what it does.

Traditional and Topical Uses

Long before chemists isolated NDGA, Indigenous peoples of the desert Southwest were using creosote bush medicinally. Tribes including the Cahuilla, Pima, and Apache traditionally applied poultices made from the leaves and stems to treat skin infections, wounds, fungal problems, and joint pain.⁶ The plant’s strong resinous scent, which gives it the common name “creosote bush” (though it is unrelated to industrial creosote), is instantly recognizable to anyone who has been in the desert after rain.

Modern research has revisited some of these topical applications. Recent hydrogel formulations using creosote bush extract enhanced the adhesion of fibroblasts, the cells that knit wounds together, and promoted wound healing in animal models without causing cell toxicity. For skin conditions, topical application of controlled-extract preparations appears to be the safest route, since it avoids the systemic toxicity issues that plague oral consumption. The anti-inflammatory, antioxidant, and antimicrobial properties of NDGA make it a reasonable candidate for treating problems like eczema, infected wounds, and fungal skin conditions when applied externally.

A Brief Career as a Food Preservative

NDGA’s powerful antioxidant properties attracted the food industry early on. During the 1950s, it was widely used as a food preservative and to protect natural fibers from degradation. That era was short-lived. Reports of toxicity emerged, and by the early 1960s NDGA was banned for food use.⁷ The U.S. Food and Drug Administration removed it from the “generally recognized as safe” list, and it has remained off-limits for food applications since. Despite this, supplements marketed as “chaparral” (another name for the creosote bush) have continued to be sold in the United States and Mexico, sometimes promoted with sweeping health claims that the regulatory history would suggest deserve skepticism.

The Liver Problem

The toxicity that ended NDGA’s food-additive career centers on the liver. In a clinical review of chaparral-associated liver damage, patients developed jaundice and severely elevated liver enzymes anywhere from three to 52 weeks after starting to ingest chaparral products. Most cases resolved within one to 17 weeks after stopping intake, but four individuals progressed to cirrhosis, and two experienced acute fulminant liver failure requiring transplants.⁸ The predominant pattern was characterized as toxic or drug-induced cholestatic hepatitis, meaning the bile ducts inside the liver were the primary site of damage.

Animal studies have confirmed the mechanism. NDGA causes a time-dependent and dose-dependent increase in alanine aminotransferase, a standard marker of liver injury. Liver cells in isolation are quite sensitive to the compound. Researchers have identified glucuronidation, a process where the liver attaches a sugar-derived molecule to NDGA, as a likely detoxification route. Both mono- and diglucuronide conjugates form when NDGA enters the bloodstream, and human liver microsomes produce the monoglucuronide in vitro, suggesting this is how the human body tries to render NDGA harmless.⁹ When the dose overwhelms this detoxification capacity, liver damage results.

The kidneys are also vulnerable. In a rat model, NDGA exposure produced cystic kidney disease through a distinctive mechanism: the compound triggered cell proliferation in the collecting tubules, forming tiny polyps that partially blocked the flow of urine through individual nephrons. Every obstructed tubule traced in the study had polyps impinging on its outflow lumen, and the resulting back-pressure contributed to cyst formation.¹⁰ This kidney toxicity, combined with the liver findings, makes oral consumption of raw NDGA or chaparral supplements a genuinely risky proposition.

Lifespan Extension in Male Mice

One of the more striking findings in NDGA research came from the National Institute on Aging’s Interventions Testing Program, which evaluates compounds for their ability to extend lifespan in genetically diverse mice across multiple independent laboratories. In one of these studies, NDGA significantly increased lifespan in male mice, with a pooled p-value of 0.0006, while aspirin, tested in parallel, also showed a benefit though with a weaker statistical signal.¹¹ A follow-up study confirmed and refined the finding: NDGA increased male median lifespan by roughly 8 to 10 percent across three different doses.¹²

The sex difference here is stark and consistent. Females showed no lifespan benefit from NDGA, even when given at a dose that produced blood levels comparable to those in the males that did benefit.¹³ The researchers suspected sex differences in how the drug is absorbed, distributed, or metabolized, rather than a fundamental biological difference in the aging pathways involved.¹⁴ It is worth emphasizing that these are mouse results, not human ones. But the Interventions Testing Program is about as rigorous as mouse aging research gets: the studies use genetically heterogeneous animals, are run at three separate sites simultaneously, and are pre-registered. NDGA is one of only a handful of compounds that has cleared this bar.

Mechanistically, one study found that NDGA inhibits p300, a protein that acts as a molecular switch controlling gene activity, and that this inhibition activates autophagy, the cell’s housekeeping process for breaking down and recycling damaged components.¹⁵ Autophagy is increasingly recognized as a key process in healthy aging, and several other life-extending interventions, including caloric restriction, also boost it.

Cancer Research and the Terameprocol Story

NDGA itself has shown anticancer activity in cell and animal models, including the ability to suppress a central growth-signaling hub called mTORC1 in breast cancer cells. Blocking this pathway reduced the expression of proteins that drive cell proliferation, new blood vessel growth, and adaptation to low-oxygen conditions inside tumors.¹⁶ But NDGA’s toxicity problems have pushed researchers toward chemically modified versions that might retain the anticancer properties while being safer to administer.

The most clinically advanced of these derivatives is terameprocol, also known as tetra-O-methyl NDGA, in which each of the four hydroxyl groups on NDGA has been capped with a methyl group. Terameprocol works by blocking the activity of a transcription factor called Sp1, which tumors rely on to produce survival proteins. In non-small cell lung cancer cells, terameprocol enhanced the effectiveness of radiation therapy, making cancer cells more sensitive to radiation damage.¹⁷

Terameprocol has been tested in a multicenter phase 1 clinical trial (called GATOR) for patients with recurrent high-grade gliomas, aggressive brain tumors with very poor prognoses. When given intravenously, the maximum tolerated dose was 1,700 mg per day. The trial then tested oral formulations to see whether sustained blood levels could be achieved more practically. Twenty patients received escalating oral doses up to 6,000 mg per day without major toxicities. However, the trial hit a pharmacokinetic wall: increasing the oral dose did not increase how much drug actually reached the bloodstream, even when patients took it with food. Peak blood levels from oral dosing remained well below what the intravenous formulation achieved.¹⁸ This absorption ceiling is a recurring challenge in bringing NDGA-family compounds to the clinic.

Anti-Inflammatory and Cardiovascular Effects

The inflammation-fighting properties of NDGA extend beyond simple enzyme inhibition. In cell culture experiments, NDGA blocked the signaling cascade that inflammatory molecules use to make blood vessel walls stickier. When immune cells are recruited to an injury or infection, one of the first things that happens is that endothelial cells lining the blood vessels start displaying adhesion molecules on their surface so that passing white blood cells can grab on and squeeze through into the tissue. NDGA pretreatment reduced the movement of a key signaling protein from the cytoplasm into the nucleus of endothelial cells, dampening this adhesion response.¹⁹

This vascular effect has implications for cardiovascular disease. In experiments using extracts from Larrea divaricata, NDGA was identified as the primary driver behind reductions in LDL oxidation and protection of HDL structure under high-glucose conditions that mimic what happens in poorly controlled diabetes. The extract cut nitric oxide production by about half and reduced free radical levels by a similar margin in exposed immune cells.²⁰ Oxidized LDL is a central villain in atherosclerosis, the process that leads to plaque buildup in arteries, so the ability to prevent that oxidation is at least theoretically relevant. But again, these are cell-culture and test-tube findings, not clinical outcomes in human patients.

Antiviral and Antimicrobial Activity

NDGA has shown inhibitory effects against a surprisingly broad range of viruses in lab settings, including dengue virus serotypes 2 and 4, with more recent work extending this to dengue serotype 1 as well.²¹ The mechanisms appear to involve interference with viral replication machinery rather than direct killing of the virus particle.

On the bacterial and fungal side, a 2025 study found that NDGA has potent activity against methicillin-resistant Staphylococcus aureus (MRSA) and the yeast Candida albicans. NDGA could eradicate persister cells, the dormant, antibiotic-tolerant subpopulations that make chronic infections so difficult to treat, and it disrupted mature biofilms from both organisms.²² Biofilms are the slimy, structured communities that bacteria and fungi build on surfaces like medical devices, wounds, and mucous membranes, and they are a major reason why infections recur even after aggressive antibiotic therapy. A compound that can penetrate and dismantle these structures is genuinely noteworthy, though the jump from lab dish to clinical use remains large.

Neurological Research

Two lines of preclinical evidence suggest NDGA may have neuroprotective properties. In a fruit fly model of Parkinson’s disease, dietary NDGA produced a dose-dependent delay in the loss of climbing ability, one of the standard measures of motor function decline in flies engineered to mimic the disease.²³

In a mouse model of amyotrophic lateral sclerosis (ALS), oral NDGA extended median total lifespan by about 10 percent when treatment was started relatively late in the disease course, at 90 days of age. Life expectancy after the start of treatment increased by roughly a third. The compound also reduced the brain inflammation and a marker of axon damage that accompany ALS progression in these mice.²⁴ The researchers attributed the benefit largely to NDGA’s inhibition of 5-lipoxygenase and its ability to dampen microglial activation, which is the brain’s version of runaway inflammation. ALS has been notoriously resistant to therapeutic intervention, and while mouse-model results have a dismal track record of translating to human patients in this disease, the findings at least identify a plausible mechanism worth studying.

Why NDGA Has Not Become a Drug

Reading the list of NDGA’s biological activities, you might wonder why no one has turned it into a medicine. The answer involves several converging problems. The liver and kidney toxicity documented in humans and animals creates a narrow window between a helpful dose and a harmful one. The compound is poorly absorbed orally, and as the terameprocol glioma trial showed, even chemically modified versions struggle with bioavailability: higher oral doses do not necessarily mean more drug in the blood.²⁵ The sex-specific lifespan effects in mice add another layer of uncertainty about how findings would translate to people.

Researchers have responded by pursuing two strategies. One is chemical modification, as with terameprocol, trying to preserve the therapeutic activity while masking the toxic hydroxyl groups. The other is formulation science, exploring delivery systems like liposomes or hydrogels that might get useful amounts of the drug to a target tissue without flooding the liver. The hydrogel approach has shown early promise for wound healing, where topical delivery sidesteps the systemic toxicity issue entirely.²⁶

NDGA and the Ecology of Empty Desert

If you have ever walked through a creosote flat and noticed how little else grows between the bushes, you have seen NDGA’s ecological role in action. The compound leaches from fallen leaves and roots into the surrounding soil, where it stunts the root development of competing seedlings. In controlled experiments, NDGA reduced root growth of eight different plant species across grasses, broadleaf plants, and legumes.²⁷ Because root suppression happens without preventing germination, seeds can sprout but cannot establish. This creates the illusion of barren ground between creosote bushes when in fact the soil may be full of chemical warfare residue.

The evolutionary calculus here is interesting. Producing NDGA in such high concentrations is metabolically expensive. But the compound pulls triple duty for the bush: it deters herbivores with its bitter resinous taste, protects the plant’s tissues from oxidative sun damage in the brutal desert environment, and poisons competitors in the soil. Some clonal creosote bush rings in the Mojave Desert are estimated to be thousands of years old, making them among the oldest living organisms on Earth. NDGA’s multifunctional role in the plant’s defense almost certainly contributes to that extraordinary longevity.